强生JNJ财报
NYSE · 医疗保健 · 制药
强生是美国跨国制药、生物技术及医疗技术企业，总部位于新泽西州新不伦瑞克，在纽约证券交易所上市，普通股为道琼斯工业平均指数成分股，2025年位列财富美国500强第48位、福布斯全球企业2000强第42位。
主要股东
| 股东 | 持股比例 | 股数 | 变动 | 截至 |
|---|---|---|---|---|
| S.S. OR | 17.00% | 4.1M | ▲ +8.40pp | 2024-11-01 |
| The Vanguard Group | 9.53% | 229.4M | — | 2024-02-13 |
| BlackRock, Inc. | 7.70% | 186.3M | — | 2024-01-26 |
| Johnson & Johnson | 6.80% | 2.5M | ▼ -2.00pp | 2024-10-18 |
| STATE STREET CORPORATION | 5.52% | 478.2M | — | 2024-01-30 |
内部人交易
Net 90d: −$80.48M · buys $0 / sells $80.48M时间范围:
类型:
身份:
| 内部人 | 身份 | 类型 | ||||
|---|---|---|---|---|---|---|
| 2026-02-27 | Decker Robert J | VP Corporate Controller | Option exercise | 4.1K | $115.67 | $471.4K |
| 2026-02-27 | Decker Robert J | VP Corporate Controller | Sell (open market) | 4.1K | $247.87 | $1.01M |
| 2026-02-20 | Timothy Schmid | EVP, WW Chair, MedTech | Sell (open market) | 1.3K | $245.66 | $324.8K |
| 2026-02-18 | Timothy Schmid | EVP, WW Chair, MedTech | Option exercise | 13.6K | $115.67 | $1.58M |
| 2026-02-18 | Timothy Schmid | EVP, WW Chair, MedTech | Sell (open market) | 13.6K | $244.20 | $3.33M |
| 2026-02-18 | Timothy Schmid | EVP, WW Chair, MedTech | Option exercise | 9.0K | $129.51 | $1.17M |
| 2026-02-18 | Timothy Schmid | EVP, WW Chair, MedTech | Sell (open market) | 9.0K | $244.53 | $2.20M |
| 2026-02-17 | Swanson James D. | EVP, CIO | Option exercise | 20.5K | $164.62 | $3.38M |
| 2026-02-17 | Swanson James D. | EVP, CIO | Sell (open market) | 20.5K | $242.70 | $4.98M |
| 2026-02-17 | Wolk Joseph J | Exec VP, CFO | Option exercise | 19.2K | $115.67 | $2.23M |
1–10 of 74
第 1 页 / 共 8 页